ARTICLES BY DAN SCHELL

  • Why Aren't We Using More Wearables In Clinical Trials?
    1/6/2025

    Wearables provide a great means for passive data collection in clinical trials, but implementing them isn’t as easy at it seems. Lauren Sunshine, director, product management, digital health, at BMS, talks about some of the advantages — and challenges — of incorporating DHTs into your trial protocols. 

  • 8 Essentials For Using DHTs In Clinical Trials
    12/5/2024

    Planning to use some type of digital health technology (DHT) in clinical trials? Maybe some type of wearable, for instance? Then be sure to check out these eight key takeaways from the FDA’s Digital Health Technologies for Remote Data Acquisition in Clinical Investigations Guidance.

  • What's The Deal With eConsent?
    10/11/2024

    Are you for or against eConsent? It’s odd that this technology has kind of become a polarizing topic in the clinical trials industry. To find out why, I decided to get some feedback from folks who have actually used it. 

  • Not What I Expected From A Vendor Conference
    9/12/2024

    Dan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites. 

  • Early Planning Trumps eCOA Bells & Whistles
    8/16/2024

    Julie Dietrich is a huge advocate for detailed documentation and early planning when it comes to successfully implementing eCOA systems. A good old-fashioned focus group couldn’t hurt either, she says.

  • Why We Need Technology Consolidation In Clinical Trials
    8/16/2024

    As more and more trial designs incorporate technologies that generate an immense amount of data, data managers struggle to continuously interconnect disparate systems and standardize data. All of this fuels the need for technology consolidation.

  • Some Truths You Can't Avoid About eCOA
    8/13/2024

    The advantages of eCOA systems often overshadow some of the potential challenges they could create. Robert Goldman expounds on some of his first-hand experiences over the years with ePRO and eCOA implementations that went awry.

Dan_2023_4_72DPI

Dan Schell



Dan Schell is Chief Editor of Clinical Leader where he writes about topics related to clinical trial operations. Previously, he served as the Editorial Director of Life Science Leader magazine, another Life Science Connect community, for 14 years. In this role, he worked with the publication’s internal and external writers and editors on choosing the best topics for articles as well as refining all content to meet Life Science Leader’s high editorial standards. Prior to his work with Life Science Leader, he worked as an editor and copy editor for the publication’s parent company, VertMarkets (now called Life Science Connect). He joined the company in 2000 after 10 years of working for Encompass Health (previously Healthsouth) in marketing and business development and four years at an advertising agency.